Karin Coradin

Karin Coradin, MBA, CAAM serves as the Head of Business Development for Core Pathogens at CEPI, where responsibilities include leading a team to identify suitable partners for disease programs and managing deal structures for vaccine development. With over 12 years at Novartis, Karin held various roles including Global Director of Corporate Strategy and BD&L, focusing on portfolio strategy, business development, and alliance management. Karin's experience also encompasses digital transformation, commercial operations, global marketing, and technical operations, alongside a foundational role as a Signatory Pharmacist at Drogasil and research at Escola Paulista de Medicina. Educational qualifications include multiple MBAs and a degree in Pharmacology and Biochemistry.